Prime Medicine, Inc. - Common Stock (NQ:PRME)
  4.955
  
   
    +0.605 
    (+13.91%)
   
  
  
  Streaming Delayed Price
  Updated:  3:36 PM EDT, Oct 31, 2025
  Add to My Watchlist
 
 
 Price and Volume
Detailed Quote| Volume | 5,296,611 | 
| Open | 4.370 | 
| Bid (Size) | 4.950 (37) | 
| Ask (Size) | 4.960 (31) | 
| Prev. Close | 4.350 | 
| Today's Range | 4.310 - 5.025 | 
| 52wk Range | 1.110 - 6.940 | 
| Shares Outstanding | N/A | 
| Dividend Yield | N/A | 
Top News
More NewsPerformance
More News
Read More
    Prime Medicine to Participate in Upcoming Investor Conferences
    
   
   
  October 07, 2025
   
    My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
    
   
  September 18, 2025
   
    Prime Medicine to Participate in Upcoming Investor Conferences
    
   
   
  August 26, 2025
   
    PRME Revenue Misses by 73%
    
   
  August 07, 2025
   
    Prime Medicine Announces Pricing of Public Offering
    
   
   
  July 30, 2025
   Frequently Asked Questions
Is Prime Medicine, Inc. - Common Stock publicly traded?
   Yes, Prime Medicine, Inc. - Common Stock is publicly traded.
  What exchange does Prime Medicine, Inc. - Common Stock trade on?
   Prime Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
  What is the ticker symbol for Prime Medicine, Inc. - Common Stock?
   The ticker symbol for Prime Medicine, Inc. - Common Stock is PRME on the Nasdaq Stock Market
  What is the current price of Prime Medicine, Inc. - Common Stock?
   The current price of Prime Medicine, Inc. - Common Stock is 4.955
  When was Prime Medicine, Inc. - Common Stock last traded?
   The last trade of Prime Medicine, Inc. - Common Stock was at 10/31/25 03:36 PM ET
  
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


